Pharmacon Care Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 04-01-2025
- Paid Up Capital ₹ 0.90 M
as on 04-01-2025
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -82.04%
(FY 2024)
- Profit -55.95%
(FY 2024)
- Ebitda -83.20%
(FY 2024)
- Net Worth -249.50%
(FY 2024)
- Total Assets -2.97%
(FY 2024)
About Pharmacon Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Kizhakkiveettil Manojkumar, Vasudevan Santhosh, and Pradeep Pengattu serve as directors at the Company.
- CIN/LLPIN
U51909KL2021PTC069470
- Company No.
069470
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Pharmacon Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kizhakkiveettil Manojkumar  | Managing Director | 18-Jun-2021 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vasudevan Santhosh | Director | 18-Jun-2021 | Current |
| Pradeep Pengattu | Director | 18-Jun-2021 | Current |
Financial Performance of Pharmacon Care.
Pharmacon Care Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 82.04% decrease. The company also saw a substantial fall in profitability, with a 55.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 249.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmacon Care?
Unlock access to Pharmacon Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Clivia Pharma Private LimitedActive 14 years 4 monthsKizhakkiveettil Manojkumar, Vasudevan Santhosh and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmacon Care?
Pharmacon Care has a workforce of 0 employees as of Jan 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmacon Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacon Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
